베타
임상 레이더 AI
임상시험 NCT06377254 (CHAIN)은(는) 좌식 행동, 대사 증후군, 연령 관련 인지 저하, 연령 관련 근감소증에 대해 모집중 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요.
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰

Multi-organ Responses to CHronic Physical Activity and INactivity (CHAIN)

모집중
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '시험 설명하기'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT06377254 (CHAIN)은(는) 좌식 행동, 대사 증후군, 연령 관련 인지 저하, 연령 관련 근감소증에 대해 알아보는 중재연구입니다. 현재 상태는 모집중이며, 연구는 2024년 3월 12일에 시작되어 40명의 참여자를 모집하고 있습니다. University of Nottingham이(가) 진행하며, 2028년 10월 31일까지 완료될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2025년 12월 4일에 갱신되었습니다.
간단한 개요
Life expectancy has been increasing for the last 150 years, but the maintenance of health has not kept pace with increased lifespan, and on average, UK adults spend the last decade of life in poor-health, with major consequences for society and the individual.

Persistent physical inactivity is thought to be a key contributing factor to the risk of poor health and functional decline occurring in middle-aged and older adults. It is therefore concerning that most middle-aged adults spend >8hrs/day being sedentary, with average step count of 3000-4000 steps/day.

To be able to holistically assess the effectiveness of future strategies to address age-related decline in health, and devise public health messages to help individuals reach older age in better health, it is essential that the complex physiological effects that activity and inactivity have across biological systems are characterised.

The goal of this intervention study is to compare the impact of physical activity and inactivity on body functioning. Twenty moderately active participants will decrease their physical activity for three months to match the average amount carried out by middle-aged people in the UK. They will then undertake 3-months of reconditioning training to restore their fitness. In addition, twenty sedentary participants will increase their physical activity to UK recommended levels for six months.

Before and at points during the intervention period, participants will be asked to make some measurements at home and attend the University of Nottingham to have multiple assessments made. These include;

  • fitness, muscle strength and function tests,
  • completion of questionnaires and computer-based brain puzzles
  • having muscle and fat tissue biopsies and blood samples taken.
  • The study also involves having MRI scans.

This 5-year study will commence in January 2024, with participant recruitment starting in March 2024 and finishing in May 2027.

상세한 설명
This is a parallel design study comparing the impact of physical activity and inactivity on the way the body functions, to understand the mechanisms (including the inter-relationship between tissues and organs) by which lifestyle behaviours may effect health and wellbeing in later life. In particular, the mechanisms by which inactivity results in long term poor health is not well understood, and has rarely been studied in an integrated way in people. However, initial research indicates that the physiology of being inactive is not simply the reverse of being active. To enable effective treatments and public health advice to be devised so that more adults reach old age in better health, and maintain a good quality of life for a greater proportion of their older age, it is important that the impact of physical inactivity on the way the body functions is better understood. Therefore, twenty participants who are moderately, but not highly active will be asked to decrease their physical activity for three months to match the average exercise levels of middle-aged people in the United Kingdom (UK). This will require them to increase their daily sitting time to 7 hours a day and reduce their step count to <4500 steps per day. At the end of the 3-months they will undertake 3-months of supervised reconditioning training by attending the Medical School at Queen's Medical Centre, Nottingham, three times a week.

In addition, twenty participants who currently have low physical activity levels will be asked to increase their physical activity to UK recommended levels by attending the Medical School at Queen's Medical Centre, Nottingham, three times a week for six months to undertake a supervised exercise program.

Before and during the 6-month period (at weeks 6, 12, 18 and 24) participants will be asked to make some measurements at home (physical activity levels, dietary intake) and attend the University of Nottingham over 4 days to have multiple assessments made. These include: height; weight; body composition (body fat and lean tissue); blood pressure; fitness, muscle strength and function; sleep quality, quality of life and wellbeing (questionnaires). The rate of muscle protein breakdown and muscle protein synthesis, blood sugar regulation, and biochemistry of the blood, fat tissue and muscles will be assessed, and to enable this muscle and fat tissue biopsies will be collected and blood samples taken. The study also involves having MRI scans to study the structure and function of the brain and heart, and to determine liver and muscle fat content.

공식 제목

Concurrent Multi-organ Responses to CHronic Physical Activity and INactivity Intervention, to Increase Research Discovery in Human Health and Wellbeing

질환/상태
좌식 행동대사 증후군연령 관련 인지 저하연령 관련 근감소증
기타 연구 식별자
  • CHAIN
  • BB/X015173/1
NCT 번호
실제 연구 시작일
2024-03-12
최신 업데이트 게시
2025-12-04
예상 연구 완료일
2028-10-31
계획된 등록 인원
40
연구종류
중재연구
단계/상
해당 없음
상태
모집중
키워드
Physical activity
middle-age
Physical inactivity
overweight
lifestyle
주요 목적
기초과학
설계 할당
비랜덤화 배정
중재 모델
평행설계
맹검 (마스킹)
단일맹검
시험군 / 개입
참가자 그룹/시험군개입/치료
실험적Inactivity
Participants in this group will reduce their physical activity (increase sitting time to 7hrs/day and decrease step count to \<4500/day) for 3 months, then increase their activity for 3 months, through attending 3x 45 min supervised exercise sessions/week.
Decreased Physical Activity
Physical activity levels will be decreased
실험적Activity
Participants in this group will have moderate intensity physical activity levels increased for 6 months, through attending 3x 45 min supervised exercise sessions/week.
Increased Physical Activity
Physical activity levels will be increased
주요결과변수
결과변수측정값 설명시간 범위
Change in Cardiorespiratory fitness (VO2 max)
change in maximal oxygen uptake (continuous incremental bicycle ergometer exercise test with on-line gas analysis) measured every 6 weeks
12 weeks
이차결과변수
결과변수측정값 설명시간 범위
Change in Isometric leg strength
Change in Isometric leg strength measured every 6 weeks using CYBEX dynamometer
24 weeks
Change in time to leg fatigue
Change in time taken to induce muscle fatigue measured every 6 weeks using isokinetic knee extensions on a CYBEX dynamometer
24 weeks
Change in incremental area under the curve (iAUC) for blood glucose concentration
Change in 180 minute blood glucose concentration incremental area under the curve measured every 6 weeks during an oral glucose tolerance test.
24 weeks
Change in iAUC for serum insulin concentration
Change in 180-minute serum insulin concentration incremental area under the curve measured every 6 weeks during an oral glucose tolerance test
24 weeks
Change in fasting glucose oxidation rate
Change in glucose oxidation rate (when fasted), measured every 6 weeks using ventilated hood indirect calorimetry
24 weeks
Change in 'fed' glucose oxidation rate
Change in glucose oxidation rate (in the insulin-stimulated 'fed' state), measured every 6 weeks using ventilated hood indirect calorimetry during an oral glucose tolerance test
24 weeks
Change in Short Form Health Survey (SF36) Questionnaire aggregated normalised 'physical' score
Change in 'SF36' Questionnaire aggregated 'physical' score (normalised to UK population) calculated according to standard procedures (min 0, max 100), with higher score indicating better physical wellbeing measured every 6 weeks
24 weeks
Change in Short Form Health Survey (SF36) Questionnaire aggregated and normalised 'mental' score
Change in 'SF36' Questionnaire aggregated 'mental' score (normalised to UK population) calculated according to standard procedures (min 0, max 100), with higher score indicating better mental wellbeing, measured every 6 weeks
24 weeks
Change in World Health Organisation Quality of Life (WHOQoL) score
Change in World Health Organisation Quality of Life Score (measured using the WHOQoL-Bref questionnaire every 6 weeks), (min score 0, max 100), with higher score indicating a better state of health.
24 weeks
Change in Pittsburgh Sleep Quality Index (PSQI)
Change in PSQI score (min score 0, max 21), measured every 6 weeks, with higher score indicating poorer sleep quality
24 weeks
Change in Stroop test; % Accuracy
Change in the percentage of accurate responses, measured every 6 weeks, with higher score indicating better cognitive performance. Minimum value 0%, maximum value 100%
24 weeks
Change in Stroop test; reaction time
Change in the reaction time for responses, measured every 6 weeks, with higher score indicating slower cognitive performance. No minimum or maximum value defined.
24 weeks
Change in four-choice reaction time test; % Accuracy
Change in the percentage of accurate responses, measured every 6 weeks, with higher score indicating better cognitive performance. Minimum value 0%, maximum value 100%
24 weeks
Change in four-choice reaction time test; reaction time
Change in the reaction time for responses, measured every 6 weeks, with higher score indicating slower cognitive performance. No minimum or maximum value defined.
24 weeks
Change in card sort test; % Accuracy
Change in the percentage of accurate responses, measured every 6 weeks, with higher score indicating better cognitive performance. Minimum value 0%, maximum value 100%
24 weeks
Change in card sort test; reaction time
Change in the reaction time for responses, measured every 6 weeks, with higher score indicating slower cognitive performance. No minimum or maximum value defined.
24 weeks
Change in Logical reasoning test; % accuracy
Change in the accuracy of responses, measured every 6 weeks, with higher score indicating better cognitive performance. Minimum value 0%, maximum value 100%
24 weeks
Change in Logical reasoning test; reaction time
Change in the reaction time for responses, measured every 6 weeks, with higher score indicating slower cognitive performance. No minimum or maximum value defined.
24 weeks
Change in serial subtractions test; number of responses in 2 minutes
Change in the number of responses, measured every 6 weeks, with higher score indicating better cognitive performance. minimum number is 0, maximum number is variable dependent on starting value (800-999; randomly selected by computer program) and speed of response.
24 weeks
Change in Corsi blocks test; score
Change in the test score, measured every 6 weeks, with higher score indicating better cognitive performance.Minimum score is 0 and maximum is 15.
24 weeks
Change in Muscle protein synthesis rate
Muscle synthesis protein rate calculated from deuterium incorporation into muscle tissue
24 weeks
Change in Muscle protein breakdown rate
Muscle protein breakdown rate calculated every 6 weeks using 3-methylhistidine tracer
24 weeks
Change in whole body fat volumes
Change in the amount of fat within the body, measured every 6 weeks using magnetic resonance imaging (MRI)
24 weeks
Change in liver fat volumes
Change in the amount of fat within the liver, measured every 6 weeks using magnetic resonance imaging (MRI)
24 weeks
Change in thigh muscle fat volumes
Change in the amount of fat within the vastus lateralis thigh muscle, measured every 6 weeks using magnetic resonance imaging (MRI)
24 weeks
Change in whole body muscle volumes
Change in the amount of muscle within the body, measured every 6 weeks using magnetic resonance imaging (MRI)
24 weeks
Change in muscle phosphocreatine synthesis rate
Change in the rate of phosphocreatine synthesis, measured every 6 weeks using magnetic resonance spectroscopy
24 weeks
Change in cerebral volume
Change in the volume of brain tissue, measured every 6 weeks using magnetic resonance imaging (MRI)
24 weeks
Change in cortical thickness
Change in the thickness of the brain cortex, measured every 6 weeks using magnetic resonance imaging (MRI)
24 weeks
Change in plasma metabolome
change in untargeted plasma metabolome profile measured every 6 weeks
24 weeks
적격성 기준

연령대
성인, 노인
최소 연령
50 Years
참여 가능한 성별
전체
건강한 참가자 허용
  • Group 1 ('non-sedentary') self-reporting <6 sedentary hrs/day, not actively involved in exercise training or a regular physical activity regimen (>8,000 steps/day).
  • Group 2 ('sedentary') self-reporting ≥8 waking hrs/day in sedentary activities and/or ≤5,000 steps/day.
  • Aged 50-65y.
  • Overweight (BMI 25-35 kg/m2).
  • Waist circumference ≥94cm (males) and ≥80cm (females).
  • Willing to alter physical activity levels as instructed for 6 months
  • Without neurological or psychiatric diseases, motor or cognitive restrictions
  • Ability to give informed consent

  • Regular medication use that could interfere with measures
  • A history, or evidence, of chronic cardiovascular, metabolic, musculoskeletal, renal or respiratory diseases.
  • Experiencing 'long-COVID', inflammatory bowel disease or malignancy.
  • Uncontrolled hypertension. Stage 1 hypertension (BP ≤160/100mmHg) with no other signs of cardiovascular disease, and blood pressure (BP) managed by routine medication will not be an exclusion.
  • People employed in jobs that would preclude reducing step count and night-shift workers.
  • Females who are pre/peri-menopausal, (due to effect of oestrogen fluctuations on primary outcomes and the longitudinal study design), but individuals stable on hormone replacement therapy are eligible.
  • Contraindications for MRI.
  • Allergy or sensitivity to local anaesthesia, or dressing adhesive
University of Nottingham logoUniversity of Nottingham
Biotechnology and Biological Sciences Research Council logoBiotechnology and Biological Sciences Research Council
연구 책임자
Paul Greenhaff, 책임연구자, Principal Investigator, University of Nottingham
연구 대표 연락처
연락처: Paul L Greenhaff (PI), PhD, +44 (0) 1158230133, [email protected]
연락처: Melanie Tooley (participant recruitment), BSc, +44 (0) 115 9515151, [email protected]
1 1개국에 임상시험 장소

Notts

David Greenfield Human Physiology Unit, Nottingham, Notts, NG72UH, United Kingdom
Sara Brown, 연락처, +44(0)115 8230434, [email protected]
Joanne Mallinson, PhD, 연락처, +44(0)1158230434, [email protected]
Paul Greenhaff, PhD, 책임연구자
Liz Simpson, PhD, 공동연구자
Joanne Mallinson, PhD, 공동연구자
Abhishek Sheth, MD, 공동연구자
Penny Gowland, PhD, 공동연구자
Sue Francis, PhD, 공동연구자
Rosemary Nicholls, PhD, 공동연구자
Sara Brown, 공동연구자
Donald Peden, PhD, 공동연구자
Alena Ponitzova, 공동연구자
모집중